Titan Pharmaceuticals, Inc.
TTNP · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $1,955 | $2,803 | $1,945 | $2,831 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $232 | $143 | $81 | $62 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $95 | $105 | $130 | $30 |
| Total Curr. Assets | $2,282 | $3,051 | $2,156 | $2,923 |
| Property Plant & Equip (Net) | $5 | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $5 | $0 | $0 | $0 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $2,287 | $3,051 | $2,156 | $2,923 |
| Liabilities | – | – | – | – |
| Payables | $261 | $219 | $194 | $202 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $41 | $44 | $85 | $281 |
| Total Curr. Liab. | $302 | $263 | $279 | $483 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $0 | $0 | $0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $302 | $263 | $279 | $483 |
| Equity | – | – | – | – |
| Pref Stock | $1 | $1 | $1 | $1 |
| Common Stock | $1 | $1 | $1 | $1 |
| Retained Earnings | -$398,591 | -$397,788 | -$397,099 | -$396,536 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $400,574 | $400,574 | $398,974 | $398,974 |
| Total Equity | $1,985 | $2,788 | $1,877 | $2,440 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $2,287 | $3,051 | $2,156 | $2,923 |
| Net Debt | -$1,955 | -$2,803 | -$1,945 | -$2,831 |